IVRN (Innoveren Scientific) Other Long-Term Liabilities: $2.02 Mil (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IVRN Innoveren Scientific Inc IVRN
16 GF Score
Price $0.00
View Full Analysis

What is Innoveren Scientific Other Long-Term Liabilities?

Innoveren Scientific IVRN 16 Other Long-Term Liabilities is $2.02 Mil as of Sep. 2023. GuruFocus rates IVRN with a GF Score™ of 16/100.

Innoveren Scientific's other long-term liabilities for the quarter that ended in Sep. 2023 was $2.02 Mil.

Innoveren Scientific's quarterly other long-term liabilities stayed the same from Mar. 2023 ($2.02 Mil) to Jun. 2023 ($2.02 Mil) and stayed the same from Jun. 2023 ($2.02 Mil) to Sep. 2023 ($2.02 Mil).

Innoveren Scientific's annual other long-term liabilities declined from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($-0.00 Mil) but then increased from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($2.02 Mil).

Innoveren Scientific Other Long-Term Liabilities Related Terms

Innoveren Scientific Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Innoveren Scientific's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innoveren Scientific Other Long-Term Liabilities Chart

Innoveren Scientific Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.58 0.00 -0.00 2.02

Innoveren Scientific Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.70 2.02 2.02 2.02 2.02
IVRN
16GF Score
Innoveren Scientific Inc IVRN
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innoveren Scientific Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $2.02 Mil mean?
Innoveren Scientific (IVRN) has a Other Long-Term Liabilities of $2.02 Mil as of Sep. 2023. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Innoveren Scientific and its competitors.
Is Innoveren Scientific's Other Long-Term Liabilities too high?
Innoveren Scientific's current Other Long-Term Liabilities is $2.02 Mil. Overall, Innoveren Scientific has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Innoveren Scientific's Other Long-Term Liabilities compare to GNCA and ISCO?
Innoveren Scientific's Other Long-Term Liabilities of $2.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Biotechnology company?
A good Other Long-Term Liabilities depends on the Biotechnology industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Innoveren Scientific and its competitors. Innoveren Scientific's current Other Long-Term Liabilities is $2.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innoveren Scientific stock overvalued right now?
Innoveren Scientific (IVRN) has a current Other Long-Term Liabilities of $2.02 Mil. The current Other Long-Term Liabilities is $2.02 Mil. Innoveren Scientific's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Innoveren Scientific (IVRN), the current Other Long-Term Liabilities is $2.02 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innoveren Scientific Business Description

Address 2202 N West Shore Boulevard, Suite 200, Tampa, FL, USA, 33607
Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.
16GF Score

Get the complete analysis for IVRN

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price